miR-1247 is correlated with prognosis of pancreatic cancer and inhibits cell proliferation by targeting neuropilins

Current Molecular Medicine

Volumn 14, Issue 3, 2014, Pages 316-327

  Shi, S ^a,b   Lu, Y ^a,b   Qin, Y ^a,b   Li, W ^c   Cheng, H ^a,b   Xu, Y ^a,b   Xu, J ^a,b   Long, J ^a,b   Liu, L ^a,b   Liu, C ^a,b   Yu, X ^a,b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

microRNA; Neuropilin; Pancreatic cancer; Prognosis; Retinoic acid; Tumor grade

Indexed keywords

BETA ACTIN; CHOLECYSTOKININ OCTAPEPTIDE; KI 67 ANTIGEN; MICRORNA; MICRORNA 1247; NEUROPILIN; NEUROPILIN 1; NEUROPILIN 2; RETINOIC ACID; UNCLASSIFIED DRUG; NEUROPILIN-2, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER GRADING; CANCER GROWTH; CANCER INHIBITION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CANCER TISSUE; CARCINOGENICITY; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISOCHEMISTRY; IN SITU HYBRIDIZATION; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOUSE; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PANCREAS CANCER; PLASMID; PROTEIN EXPRESSION; PROTEIN TARGETING; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; TISSUE MICROARRAY; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; BIOLOGY; CELL CYCLE; GENETICS; METABOLISM; PANCREATIC NEOPLASMS; PHYSIOLOGY; TUMOR CELL LINE;

BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; HUMANS; MICRORNAS; NEUROPILIN-1; NEUROPILIN-2; NEUROPILINS; PANCREATIC NEOPLASMS; TRETINOIN;

EID: 84897398308     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524014666140228120014     Document Type: Article

References (48)

1. DeSantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer J Clin 2013; 63(3): 151-66.
2. Wolfgang CL, Herman JM, Laheru DA, et al. Recent progress in pancreatic cancer. CA Cancer J Clin 2013; 63(5): 318-48.
3. Shi S, Yao W, Xu J, Long J, Liu C, Yu X. Combinational therapy: new hope for pancreatic cancer? Cancer Lett 2012; 317(2): 127-35.
4. Xu C, Li H, Su C, Li Z. Viral therapy for pancreatic cancer: tackle the bad guys with poison. Cancer Lett 2013; 333(1): 1-8.
5. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5(7): 522-31.
6. Shen J, Stass SA, Jiang F. MicroRNAs as potential biomarkers in human solid tumors. Cancer Lett 2013; 329(2): 125-36.
7. Su Y, Li X, Ji W, et al. Small molecule with big role: MicroRNAs in cancer metastatic microenvironments. Cancer Lett 2014; 344(2): 147-56.
8. Rachagani S, Kumar S, Batra SK. MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications. Cancer Lett 2010; 292(1): 8-16.
9. Singh S, Chitkara D, Kumar V, Behrman SW, Mahato RI. miRNA profiling in pancreatic cancer and restoration of chemosensitivity. Cancer Lett 2013; 334(2): 211-20.
10. Guo S, Xu X, Tang Y, et al. miR-15a inhibits cell proliferation and epithelial to mesenchymal transition in pancreatic ductal adenocarcinoma by down-regulating Bmi-1 expression. Cancer Lett 2014; 344(1): 40-6.
11. Ouyang H, Gore J, Deitz S, Korc M. microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-beta actions. Oncogene 2013; epub ahead of print.
12. Marin-Muller C, Li D, Bharadwaj U, et al. A Tumorigenic Factor Interactome Connected through Tumor Suppressor MicroRNA-198 in Human Pancreatic Cancer. Clin Cancer Res 2013; 19(21): 5901-13.
13. Benetatos L, Hatzimichael E, Londin E, et al. The microRNAs within the DLK1-DIO3 genomic region: involvement in disease pathogenesis. Cell Mol Life Sci 2013; 70(5): 795-814.
14. Yan H, Choi AJ, Lee BH, Ting AH. Identification and functional analysis of epigenetically silenced microRNAs in colorectal cancer cells. PLoS One 2011; 6(6): e20628.
15. Anwar SL, Albat C, Krech T, et al. Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker. Int J Cancer 2013; 133(3): 660-70.
16. Plaisier CL, Pan M, Baliga NS. A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers. Genome Res 2012; 22(11): 2302-14.
17. Logsdon CD, Simeone DM, Binkley C, et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003; 63(10): 2649-57.
18. Prud'homme GJ, Glinka Y. Neuropilins are multifunctional coreceptors involved in tumor initiation, growth, metastasis and immunity. Oncotarget 2012; 3(9): 921-39.
19. Rizzolio S, Tamagnone L. Multifaceted role of neuropilins in cancer. Curr Med Chem 2011; 18(23): 3563-75.
20. Li M, Yang H, Chai H, et al. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Cancer 2004; 101(10): 2341-50.
21. Wey JS, Gray MJ, Fan F, et al. Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. Br J Cancer 2005; 93(2): 233-41.
22. Fukasawa M, Matsushita A, Korc M. Neuropilin-1 interacts with integrin beta1 and modulates pancreatic cancer cell growth, survival and invasion. Cancer Biol Ther 2007; 6(8): 1173-80.
23. Cao Y, Hoeppner LH, Bach S, et al. Neuropilin-2 promotes extravasation and metastasis by interacting with endothelial alpha5 integrin. Cancer Res 2013; 73(14): 4579-90.
24. Muders MH. Neuropilin and neuropilin associated molecules as new molecular targets in pancreatic adenocarcinoma. Anticancer Agents Med Chem 2011; 11(5): 442-7.
25. El-Metwally TH, Hussein MR, Abd-El-Ghaffar S, Abo-El-Naga MM, Ulrich AB, Pour PM. Retinoic acid can induce markers of endocrine transdifferentiation in pancreatic ductal adenocarcinoma: preliminary observations from an in vitro cell line model. J Clin Pathol 2006; 59(6): 603-10.
26. El-Metwally TH, Pour PM. The retinoid induced pancreatic cancer redifferentiation-apoptosis sequence and the mitochondria: a suggested obligatory sequence of events. JOP 2007; 8(3): 268-78.
27. Martens-Uzunova ES, Olvedy M, Jenster G. Beyond microRNA-Novel RNAs derived from small non-coding RNA and their implication in cancer. Cancer Lett 2013; 340(2): 201-11.
28. Fabbri M. MicroRNAs and cancer: towards a personalized medicine. Curr Mol Med 2013; 13(5): 751-6.
29. Nasarre P, Gemmill RM, Potiron VA, et al. Neuropilin-2 Is Upregulated in Lung Cancer Cells during TGF-beta1-Induced Epithelial-Mesenchymal Transition. Cancer Res 2013; 73(23): 7111-21.
30. Staton CA, Koay I, Wu JM, Hoh L, Reed MW, Brown NJ. Neuropilin-1 and neuropilin-2 expression in the adenomacarcinoma sequence of colorectal cancer. Histopathology 2013; 62(6): 908-15.
31. Fukahi K, Fukasawa M, Neufeld G, Itakura J, Korc M. Aberrant expression of neuropilin-1 and-2 in human pancreatic cancer cells. Clin Cancer Res 2004; 10(2): 581-90.
32. Gray MJ, Wey JS, Belcheva A, et al. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. Cancer Res 2005; 65(9): 3664-70.
33. Dallas NA, Gray MJ, Xia L, et al. Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma. Clin Cancer Res 2008; 14(24): 8052-60.
34. Muller MW, Giese NA, Swiercz JM, et al. Association of axon guidance factor semaphorin 3A with poor outcome in pancreatic cancer. Int J Cancer 2007; 121(11): 2421-33.
35. Altucci L, Gronemeyer H. The promise of retinoids to fight against cancer. Nat Rev Cancer 2001; 1(3): 181-93.
36. Michael A, Hill M, Maraveyas A, Dalgleish A, Lofts F. 13-cis-Retinoic acid in combination with gemcitabine in the treatment of locally advanced and metastatic pancreatic cancer--report of a pilot phase II study. Clin Oncol (R Coll Radiol) 2007; 19(2): 150-3.
37. Moore DF, Jr., Pazdur R, Sugarman S, et al. Pilot phase II trial of 13-cis-retinoic acid and interferon-alpha combination therapy for advanced pancreatic adenocarcinoma. Am J Clin Oncol 1995; 18(6): 525-7.
38. D'Amato NC, Howe EN, Richer JK. MicroRNA regulation of epithelial plasticity in cancer. Cancer Lett 2013; 341(1): 46-55.
39. Xie P, Sun Y, Ouyang Q, et al. Physiological oxygen prevents frequent silencing of the DLK1-DIO3 cluster during human embryonic stem cells culture. Stem Cells 2014; 32(2): 391-401.
40. Li W, Zhao XY, Wan HF, et al. iPS cells generated without c-Myc have active Dlk1-Dio3 region and are capable of producing full-term mice through tetraploid complementation. Cell Res 2011; 21(3): 550-3.
41. Oczkowicz M, Piestrzyska-Kajtoch A, Piorkowska K, Rejduch B, Rozycki M. Expression of DLK1 and MEG3 genes in porcine tissues during postnatal development. Genet Mol Biol 2010; 33(4): 790-4.
42. Yin C, Wang PQ, Xu WP, et al. Hepatocyte nuclear factor-4alpha reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region. Hepatology 2013; 58(6): 1964-76.
43. Xu WP, Yi M, Li QQ, et al. Perturbation of MicroRNA-370/Lin-28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinoma. Hepatology 2013; 58(6): 1977-91.
44. Haga CL, Phinney DG. MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network. J Biol Chem 2012; 287(51): 42695-707.
45. Luk JM, Burchard J, Zhang C, et al. DLK1-DIO3 genomic imprinted microRNA cluster at 14q32. 2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. J Biol Chem 2011; 286(35): 30706-13.
46. Liu C, Cheng H, Shi S, et al. MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3. Curr Mol Med 2013; 13(4): 467-78.
47. Wang WQ, Liu L, Xu HX, et al. Intratumoral alpha-SMA enhances the prognostic potency of CD34 associated with maintenance of microvessel integrity in hepatocellular carcinoma and pancreatic cancer. PLoS One 2013; 8(8): e71189.
48. Cheng H, Li J, Liu C, et al. Profilin1 sensitizes pancreatic cancer cells to irradiation by inducing apoptosis and reducing autophagy. Curr Mol Med 2013; 13(8): 1368-75.